Doxycycline monohydrate how supplied
| Doxycycline monohydrate |
|---|
| DOXYCYCLINE MONOHYDRATE® FDA Package Insert |
| Description |
| Clinical Pharmacology |
| Microbiology |
| Indications and Usage |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Overdosage |
| Dosage and Administration |
| How Supplied |
| Labels and Packages |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
How Supplied
Doxycycline Monohydrate Capsules 50 mg have a white opaque body with an ivory opaque cap. The capsule bears the inscription WATSON 410 in brown and 50 mg in brown. Each capsule contains doxycycline monohydrate equivalent to 50 mg of doxycycline, supplied in bottles of 100.
Doxycycline Monohydrate Capsules 75 mg have a white opaque body with a brown opaque cap. The capsule bears the inscription WATSON 2404 in black and 75 mg in black. Each capsule contains doxycycline monohydrate equivalent to 75 mg of doxycycline, supplied in bottles of 100.
Doxycycline Monohydrate Capsules 100 mg have an ivory opaque body with a brown opaque cap. The capsule bears the inscription WATSON 411 in white and 100 mg in brown. Each capsule contains doxycycline monohydrate equivalent to 100 mg of doxycycline, supplied in bottles of 50.
Store at 20° - 25°C (68° -77°F). [See USP controlled room temperature.]
Dispense in a tight light-resistant container as defined in the USP/NF.[1]
References
- ↑ "DOXYCYCLINE MONOHYDRATE (DOXYCYCLINE) CAPSULE [WATSON LABORATORIES, INC.]". Text " accessdate" ignored (help)
Adapted from the FDA Package Insert.